Lyra Therapeutics (LYRA) Insider Trading & Ownership $0.21 -0.01 (-3.70%) As of 01/3/2025 05:45 PM Eastern Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Lyra Therapeutics (NASDAQ:LYRA) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage4.69%Number OfInsiders Buying(Last 3 Years)6Amount OfInsider Buying(Last 3 Years)$24.99 MNumber OfInsiders Selling(Last 3 Years)0 Get LYRA Insider Trade Alerts Want to know when executives and insiders are buying or selling Lyra Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address LYRA Insider Buying and Selling by Quarter Lyra Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails11/10/2023Harlan WaksalInsiderBuy25,000$2.96$74,000.00 5/31/2023Nbvm Gp, LlcMajor ShareholderBuy1,805,416$2.43$4,387,160.88 5/31/2023Perceptive Advisors LlcDirectorBuy3,610,832$2.49$8,990,971.68 6/10/2022C Ann MerrifieldDirectorBuy4,000$5.05$20,200.00 5/16/2022C Ann MerrifieldDirectorBuy328$5.00$1,640.00 5/13/2022C Ann MerrifieldDirectorBuy3,500$4.81$16,835.00 4/12/2022Edward T AndersonDirectorBuy118,483$4.22$499,998.26 4/12/2022Harlan WaksalInsiderBuy236,966$4.22$999,996.52 4/12/2022Nbvm Gp, LlcMajor ShareholderBuy2,369,667$4.22$9,999,994.74 (Data available from 1/1/2013 forward) LYRA Insider Trading Activity - Frequently Asked Questions Who is on Lyra Therapeutics's Insider Roster? The list of insiders at Lyra Therapeutics includes C Ann Merrifield, Edward T Anderson, Harlan Waksal, Nbvm Gp, Llc, and Perceptive Advisors Llc. Learn more on insiders at LYRA. What percentage of Lyra Therapeutics stock is owned by insiders? 4.69% of Lyra Therapeutics stock is owned by insiders. Learn more on LYRA's insider holdings. Which Lyra Therapeutics insiders have been buying company stock? The following insiders have purchased LYRA shares in the last 24 months: Harlan Waksal ($74,000.00), Nbvm Gp, Llc ($4,387,160.88), and Perceptive Advisors Llc ($8,990,971.68). How much insider buying is happening at Lyra Therapeutics? Insiders have purchased a total of 5,441,248 LYRA shares in the last 24 months for a total of $13,452,132.56 bought. Lyra Therapeutics Key ExecutivesDr. Harlan W. Waksal M.D. (Age 71)Executive Chairman Compensation: $210.06kDr. Maria Palasis Ph.D. (Age 59)CEO, President & Director Compensation: $942.7kDr. John E. Bishop Ph.D. (Age 62)Chief Technology Officer Compensation: $662.9kDr. Carmichael S. Roberts Jr. (Age 55)Ph.D., Co-Founder Mr. Jason Cavalier (Age 51)CFO, Treasurer & Secretary Compensation: $464.11kMr. Ray KnoxVice President of OperationsMs. Ellen CavaleriSenior Vice President of Investor Relations & CommunicationsMr. Ronan P. O'Brien J.D. (Age 51)Chief Legal Officer Ms. Corinne Noyes (Age 56)Senior Vice President of Commercial Strategy & Market Development Compensation: $426.73kMs. Vineeta Belanger Ph.D.Senior Vice President of Clinical Affairs More Insider Trading Tools from MarketBeat Related Companies ICAD Insider Trading CTSO Insider Trading MODD Insider Trading LUCD Insider Trading STIM Insider Trading NXL Insider Trading SURG Insider Trading POCI Insider Trading IRIX Insider Trading NXGL Insider Trading Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Are Selling, But These 3 Stocks Are Must-Buys3 Stocks That Wall Street Insiders Can’t Stop BuyingAppLovin Insiders Sell Shares: Stock Price Indicated Higher Are 2024’s Top Insider Buys a Good Bet for 2025? Bargains Galore? 3 Stocks With Insider Buying in the Millions This page (NASDAQ:LYRA) was last updated on 1/5/2025 by MarketBeat.com Staff From Our Partners Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredStunning Trump Exec Order LeakedMost people have no clue this unassuming facility exists. Yet the minute Donald Trump takes office... ...Banyan Hill Publishing | SponsoredDeFi Coin on Verge of Breakout!The blueprint for millionaires is here. Don't let this be the missed opportunity you regret for years. Crypto 101 Media | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredI was wrong. Dead wrong. Something is stirring deep in Silicon Valley. My team and I have been watching the tech markets closely. ...Porter & Company | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lyra Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lyra Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.